PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial

✍ Scribed by Necchi, A.; Giannatempo, P.; Mariani, L.; Farè, E.; Raggi, D.; Pennati, M.; Zaffaroni, N.; Crippa, F.; Marchianò, A.; Nicolai, N.; Maffezzini, M.; Togliardi, E.; Daidone, M. G.; Gianni, A. M.; Salvioni, R.; Braud, F.

• Book ID: 121542604
• Publisher: Springer US
• Year: 2014
• Tongue: English
• Weight: 172 KB
• Volume: 32
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-014-0074-9